{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:37:20Z","timestamp":1762270640840},"reference-count":38,"publisher":"Wiley","issue":"s5","license":[{"start":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T00:00:00Z","timestamp":1096416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>This article reviews the epidemiology of cancers arising in the distal oesophagus and proximal stomach, sometimes collectively termed oesophago\u2010gastric junctional adenocarcinomas. The several complexities involved in defining this group of cancers are considered and the reported increasing trends in incidence are reviewed, together with the descriptive epidemiology. The rates of these cancers are increasing, but not as dramatically as sometimes reported. They are also more common in white males than in other ethnic groups or in females. Although several aetiological risk factors have been reported, the two most consistent are an elevated body mass index (obesity) and a history of gastro\u2010oesophageal reflux disease. Reflux is also associated with Barrett's oesophagus, an important and increasingly diagnosed premalignant lesion. The rate of progression from Barrett's oesophagus to cancer is controversial, as is the cost\u2013benefit balance of routine endoscopic surveillance of such patients. The development of molecular biomarkers to identify Barrett's oesophagus patients with high rates of malignant transformation would represent a significant advance.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02133.x","type":"journal-article","created":{"date-parts":[[2004,9,29]],"date-time":"2004-09-29T08:49:09Z","timestamp":1096447749000},"page":"55-60","source":"Crossref","is-referenced-by-count":30,"title":["Review article: oesophago\u2010gastric adenocarcinoma \u2014 an epidemiological perspective"],"prefix":"10.1111","volume":"20","author":[{"given":"D.","family":"Forman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,29]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200202000-00001"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00940.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.9.786"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460100089030"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/29.4.645"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10427"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200202000-00004"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1110"},{"key":"e_1_2_8_11_2","volume-title":"Cancer Incidence in Five Continents","author":"Parkin DM","year":"2002"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.17.1277"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914NC421_5"},{"key":"e_1_2_8_14_2","first-page":"1055","article-title":"Nutrient intake and risk of subtypes of esophageal and gastric cancer","volume":"10","author":"Mayne ST","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32963"},{"key":"e_1_2_8_16_2","first-page":"97","article-title":"Use of aspirin and other non\u2010steroidal anti\u2010inflammatory drugs and risk of esophageal and gastric cancer","volume":"7","author":"Farrow DC","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011290704728"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.2.150"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-11-199906010-00003"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008913828105"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11568"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00482-7"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00121-7"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg108"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.1.26"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(79)73400-6"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(85)80031-3"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018835324210"},{"key":"e_1_2_8_30_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-1241.1996.tb09543.x","article-title":"Heartburn, oesophagitis and Barrett's oesophagus in self\u2010medicating patients in general practice","volume":"50","author":"Corder AP","year":"1996","journal-title":"Br J Clin Pract"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.15.1972"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30297"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9302"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31599"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9849"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(99)00332-9"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.534"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1166"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.16.1316"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02133.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02133.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02133.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:45:57Z","timestamp":1695732357000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02133.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,29]]},"references-count":38,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02133.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02133.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,29]]}}}